represent the extreme spectrum of disturbance of volume control observed in all cirrhotic patients with ascites and renal sodium retention.
Afferent factors in volume control in cirrhosis (I) Traditional (underfilling) theory of the disturbance in volume regulation. In its original formulation this theory focused on formation of ascites as the primary and central event in a chain that signaled the kidney to retain salt and water [3, 41. According to this theory, decreased synthesis of albumin by the diseased liver led to reduced plasma oncotic pressure and intrahepatic venous obstruction raised the hydrostatic pressure in the portal-splanchnic vascular bed. The resulting alteration in Starling forces in the porto-splanchnic bed led to increased formation of lymph. Once the increased formation of lymph exceeded the capacity of the lymphatic system to return it to the venous system, lymph would spill into the peritoneal cavity and form ascites [51-It should be noted that rates of lymph flow in the cirrhotic patient may increase to approximately tenfold greater than the normal rate.
In the context of this traditional theory, the accumulation of ascites is thus viewed to occur at the expense of the systemic circulation which is thereby depleted. Such volume contraction then presumably activates neurohumoral signals to the kidney to retain salt and water.
This traditional theory of volume regulation in cirrhosis, however, may be modified by including other intravascular factors which are operant in patients with cirrhosis. These factors also cause a relative decrease in the circulatory arterial blood volume as compared to the vascular capacity of the circulation (Table 1) [61. This discrepancy has been referred to by some authors as a decrease in effective" blood volume. Some of these factors are anatomical, whereas others are functional. Thus, in human cirrhosis [7, 81 and canine toxic cirrhosis [9] there may be a great increase in the vascular capacity of the splanchnic and pulmonary [101 circulation. When widely developed, these vascular changes may assume the proportion of arterio-venous shunts [91 and may contribute to the reduced systemic vascular resistance that is characteristic of patients with cirrhosis [11, 121 and animals with toxic cirrhosis [13] or with chronic bile duct ligation [14] . This vascular disorder is further compounded by impairment of autonomic reflex vascular responses [15] , diminished pulmonary vasoconstriction in response to anoxia [10] and impaired pressor response to exogenous angiotensin II and noradrenaline [16] . Similar blunting of the pressor response to vasoactive agents is also seen in the dog with chronic bile duct ligation [17] and during pregnancy [18] .
Because of the sequestration of fluid in the peritoneal cavity and the generalized loss of intravascular fluid into the interstitial compartment, that is, peripheral edema, which occurs secondary to (1) portal hypertension, (2) reduced plasma oncotic pressure, (3) the gross enlargement of the capacity of the vascular bed, and (4) the loss of the normal vasoconstrictor response to a wide spectrum of neurohormonal stimuli, it is clear that patients with cirrhosis may have impaired central hemodynamics. In addition, in some patients with cirrhosis, left ventricular function is impaired [12, 19] and in others tense ascites reduces venous return (preload) to the heart [20] . With this background it is not surprising that patients with cirrhosis tolerate hemorrhage or fluid loss poorly.
Other support for the traditional "underfihling" theory includes salutary improvement in volume homeostasis following volume replenishment in these patients. For example, volume expansion may suppress the renin-angiotensin-aldosterone axis, increase the glomerular filtration rate (GFR), and cause a natriuresis and a negative salt balance in patients with cirrhosis [21] . Among the volume expansion maneuvers that have been found to increase sodium excretion are acute volume expansion with reinfusion of ascitic fluid [11, 12, 21, 22] , introduction of the peritoneo-jugular LeVeen shunt [23] [24] [25] [26] [27] [28] , "neck out" immersion which increases central blood volume [29-3 1] , surgical revision of the thoracic duct-venous junction to facilitate lymphatic return [5, 32] , and infusion of metaraminol to overcome the peripheral vasodilatation [33] . Similarly, normalization of Starling forces by surgical decompression of the portal bed in certain patients with cirrhosis may be associated with mobilization of the ascites, improvement in kidney function, and diuresis [34, 35] . Note that all these maneuvers may overcome the circulatory disturbance without improving the function of the cirrhotic liver.
Taken together, the findings mentioned above are compatible with the view that a discrepancy between the circulating volume and the vascular capacity, that is, "underfihling" [6, 141, is the primary cause of renal sodium and water retention in patients with cirrhosis. Such a view includes increased vascular capacity (peripheral vasodilatation and arteriovenous shunts) with "redistribution" of fluid into the interstitium and venous portion of the circulation in addition tO ascites formation in the peritoneal cavity. Critique of the "underfihling" concept in cirrhosis. As described in the previous section, many patients with cirrhosis show clear signs of volume depletion, which may be aggravated by vomiting, occult variceal bleeding, and excessive use of diuretics. Although, as described above, there may be dramatic improvement and natriuresis following volume repletion by several diverse measures, such improvement is at best temporary, and moreover, it occurs only in certain patients. Thus, only approximately 30 to 50% of cirrhotic patients may exhibit a natriuresis during volume expansion [11, 121 or immersion [29- 311 although the latter procedure effectively suppresses the renin-aldosterone-angiotensin axis. Similarly, surgical portal decompression in human cirrhosis is not always associated with improvement in kidney function and diuresis [331. Some of the variability in response could be due to the fact that the degree of volume replenishment achieved was adequate in some patients and inadequate in others. Nevertheless, it appears that "underfilling" cannot be the entire explanation for the renal sodium and water retention which characterizes the cirrhotic patient. Moreover, it may occur only in a certain proportion of patients with cirrhosis, perhaps at specific stages of their disease. In this respect, the results of the study of Tristani and Cohn [111 are revealing. They studied 21 patients with decompensated alcoholic cirrhosis. Thirteen patients had a low or normal cardiac index and eight had an increased cardiac index. The patients with the low cardiac index responded to volume expansion with dextran with an increase in cardiac output, 148% increase in renal blood flow, and a rise in the proportion of cardiac output delivered to the kidneys (renal fraction). The 13 patients with the initial normal or high cardiac index responded to dextran infusion with only a slight increase in cardiac index and renal blood flow.
The authors concluded that in the group with initial high or normal cardiac index "volume depletion was apparently not an important factor in their oliguric state . . . ,a mechanism other than volume depletion may contribute to renal vasoconstriction in some patients with liver failure" [111.
In this respect, it is interesting to compare systemic and renal hemodynamics in three dog models which manifest avid renal salt retention. On the one hand, the dog with constriction of the inferior vena cava represents a model of "pure" central volume depletion (underfilling) with minimal liver damage except for venous congestion. On the other hand, both the dog with chronic bile duct ligation [14, 36] and the dog with dimethylnitrosamine-induced cirrhosis [131 also retain salt and water, but differ from the caval dog since advanced parenchymal liver damage is present. The caval dog with "underfilling" of the central circulation has, as expected, a reduced cardiac output [6, 37] and increased peripheral vascular resistance [6, 37, 38] . Intrarenal administration of vasodilators or alpha-adrenergic blockade results in natriuresis [39] [40] . In contrast, the dog with This concept perceives "underfiuing" mainly as a discrepancy in the relation of the arterial vascular capacity to circulating blood volume. Under this formulation ascites formation secondary to excess lymphatic formation need not be the initial or primary event in causing the "underfilling" of the circulation.
toxic cirrhosis and the dog with chronic bile duct ligation both have increased cardiac output [13, 14] and diminished peripheral resistance [13, 14] . Intrarenal infusion of vasodilators or alpha-adrenergic blockade does not result in natriuresis in spite of renal vasodilatation [41, 42] . Thus, the systemic hemodynamic and renal vascular responses in dogs with bile duct obstruction or cirrhosis differ strikingly from the responses in dogs with uncomplicated "underfilling" of the circulation secondary to caval constriction. Finally, any "underfilling" in cirrhotic patients could be, at least in part, due to a reduction in the nonsplanchnic blood volume. This, however, has not yet been demonstrated either in human cirrhosis or in experimental canine cirrhosis. If anything, indirect measurement in human cirrhosis [7, 8] and direct measurement in the dog with toxic cirrhosis [7] show an increase in absolute nonsplanchnic blood volume during salt retention. This, of course, does not exclude a relative decrease in nonsplanchnic arterial blood volume which occurs secondary to an increase in vascular capacity during peripheral vasodilation. Nevertheless, the above information suggests that isolated volume depletion (underfilling) cannot account for the entire spectrum of the disturbed volume control in patients and animals with liver damage. There arises the need, therefore, to re-examine the traditional "underfilling" concept in cirrhosis.
(2) "Overflow" concept of ascites ftrmation in cirrhosis (Table 3 ). The traditional "underfilling" view (Tables 1 and 2) has been challenged recently and an "overflow" concept of ascites has been proposed. Based on experiments on patients with cirrhosis, Liberman, Ito, and Reynolds [7] and Lieberman, Denison, and Reynolds [8] postulated that nonvolume dependent renal sodium retention was the primary disturbance in sodium homeostasis in cirrhosis. In their view this renal sodium retention led to total plasma volume expansion including its nonsplanchnic component. The predilection of the renal salt and water retention to cause ascites was explained by the local alteration of Starling forces in the portosplanchnic bed (overflow concept). This formulation of the "overflow" concept was Table 2 . Experimental evidence supporting the "underfilling" concept in cirrhosis (1) Acute central hypervolemia induced by neck-out water immersion of patients with cirrhosis may be associated with an increase in diuresis and natriuresis, increase in GFR and suppression of elevated levels of plasma renin activity and plasma aldosterone.
(2) Acute volume expansion in patients with cirrhosis may be associated with an increase in cardiac output, renal blood flow, glomerular filtration rate, and free water clearance.
(3) Peritoneovenous (LeVeen) shunting in cirrhotic man or dog may be associated with improved systemic hemodynamics, mobilization of the ascites, increase in GFR and suppression of the elevated plasma renin activity and plasma aldosterone levels. Similar results may be obtained by portocaval shunting in man with cirrhosis.
(4) Re-anastomosis of thoracic duct to the venous system in patients with cirrhosis may be associated with mobilization of the ascites and diuresis. Table 3 . Experimental evidence supporting the "overflow" theory in cirrhosis
(1) Ascites may accumulate in patients with compensated cirrhosis following increased renal salt and water retention and hypervolemia associated with mineralocorticoid administration.
(2) As estimated by available methods, nonsplanchnic plasma volume in patients with cirrhosis does not decrease during formation of ascites and does not increase during spontaneous diuresis. (3) In dogs with toxic cirrhosis renal salt and water retention precedes formation of ascites.
(4) In dogs with toxic cirrhosis elimination of the ascites with peritoneovenous LeVeen shunt does not prevent renal salt and water retention when the diet contains liberal amounts of sodium chloride. (5) In animals with experimental liver damage and in patients with advanced cirrhosis renal sodium retention may still persist after effective blood volume has been replenished.
based on several indirect observations. First, in contrast to normal subjects patients with compensated cirrhosis accumulate ascites under the influence of exogenous mineralocorticoids [8] . Such loss of mineralocorticoid "escape" in patients with cirrhosis has later been confirmed by others [43] . More importantly, spontaneous diuresis and natriuresis have been found to occur independent of measurable changes in the volume of the nonsplanchnic vascular compartment [7, 8] . This contradicts the original "underfilling" concept which requires absolute or relative contraction of nonsplanchnic plasma volume with formation of ascites during the sodium retaining period and expansion of these compartments during diuresis.
Strong support for the "overflow" theory came from the extensive and carefully planned experiments by Levy [9, 13, 46] , Levy, Wexler, and McCaffrey, Levy and Wexler [441, and Levy and Allotey [45] . These authors studied sequentially the events that led to sodium retention and ascites following the institution of dimethylnitrosamine cirrhosis in the dog. They were also able to measure directly the changes in the volume of the vascular compartments following salt retention. The study indicated that renal sodium retention and volume expansion may precede formation of ascites by 10 days. (As little as 25 ml of ascites were detectable by needle aspiration of the peritoneal cavity.) Moreover, one third of the total increment in blood volume occurred in the nonportal compartment suggesting an increase in central ("effective") blood volume. The sodium retention was reported to occur independent of changes in cardiac output, mean arterial pressure, splanchnic blood volume, hepatic arterial blood flow, GFR, renal blood flow, intrarenal hemodynamics, aldosterone, estrogen and progesterone levels, and increased renal sympathetic nerve activity [13] .
Prevention of portal hypertension by prior construction of a portocaval fistula before induction of cirrhosis did not prevent formation of ascites [44] . Under this experimental provision the entire increase in plasma volume was confined to the nonportal compartment. Also, elimination of ascites in these cirrhotic dogs with the LeVeen shunt [33] did not prevent salt retention during liberal salt intake. Taken together, therefore, these studies support the view that the initiating event in the renal sodium retention of cirrhosis is not related to "underfilling,"
thus primary renal sodium retention has been suggested (overflow theory). One word of caution, however, should be sounded. An important, although undetectable, increase in vascular capacity, that is, peripheral vasodilatation, could have triggered the early sodium retention because cardiac output measurements, which are necessary to calculate peripheral vascular resistance, may not detect modest but critical changes in the range of 10%.
There are several additional hepatorenal influences that are apparently independent of systemic volume status and thus support the overflow theory. Hepatic venous congestion is a stimulus for aldosterone secretion and renal sodium retention [471; acute portal hypertension in the dog also causes renal sodium retention which is reversed at least in part by renal denervation [48] . A fall in cardiac output may, however, occur in this latter model. The conscious rat with chronic bile duct ligation also has diminished renal blood flow and increased renal vascular resistance in the face of normal systemic hemodynamics, plasma protein concentration and plasma volume [49] . These results, therefore, suggest that renal sodium retention may precede alterations in systemic hymodynamics and ascites formation. The mechanism remains to be defined, however, whereby renal sodium retention may initiate volume expansion and "overflow" ascites.
Critique of the "overflow" theory. The "overflow" theory is useful in alerting physicians and investigators to the possibility that in cirrhosis the kidneys may avidly retain sodium and water as a response to stimuli that are independent of volume status. Nevertheless, this concept does not explain why some of these patients and experimental animals exhibit a natriuresis in response to volume expansion or neck immersion. Also, the "overflow" theory cannot account for the stimulation of the renin-angiotensin-aldosterone axis [31, [50] [51] [52] [53] [54] and increase in plasma arginine vasopressin [55] and catecholamines [561 in patients with cirrhosis. Rather, volume expansion should suppress these parameters.
If a true and prolonged pure "overflow" situation was common in cirrhosis, a clinical profile resembling "low renin hypertension" would be expected to be seen, at least during an early state of development in patients with cirrhosis or dogs with induced liver damage. Such a profile has not been described in association with cirrhosis, independent of the stage of development. In fact, liver disease in dogs leads to hypotension [14] and correction of previously induced renal hypertension [571. Levy and Allotey [45] studied the temporal relationship between renal salt retention and alteration in systemic hemodynamics in dogs with a model of toxic cirrhosis. They interpreted their findings as demonstrating that renal salt retention and ascites occurred before ascites formation and any change in systemic hemodynamics. These findings were thus taken as evidence supporting the "overflow" theory. Inspection of their data, however, reveals that mean blood pressure decreased from 120 mm Hg before cirrhosis was induced in the dogs to 110 mm Hg when the cirrhotic dogs were in a 20 mEq/day positive sodium balance. Moreover, the most profound positive sodium balance was observed only after a substantial decrease in peripheral vascular resistance occurred. Therefore, as the authors themselves suggested, "the possibility that such urinary salt retention is secondary to subtle decrements in arterial fullness has not been excluded completely" [451. In this context, it is interesting to note that experimental animals with liver damage may have blunted pressor response to volume challenge indicating increased compliance [14] and susceptibility to shock following controlled hemorrhage [58] . Such important but subtle evidence of underfihling may not be significantly detectable by monitoring blood pressure and cardiac output for I or 2 hr per week. Such underfilling, however, may be "sensed" and signal the kidney to retain salt and water. Thus, it is obvious that neither the "underfilling" nor "overflow" theory can account exclusively for all the observed derangements in volume regulation in cirrhosis. Rather, it is quite possible that elements of the two concepts may occur simultaneously or sequentially in patients with cirrhosis. At present, therefore, it can be suggested that in cirrhosis the kidney responds to volume-independent and volume-dependent stimuli with avid sodium retention. Formation of ascites cannot be viewed as a primary or central event causing "underfihling" and initiating this perturbation in sodium balance. On the other hand, classic "overflow" phenomena such as an increase in blood pressure and a suppression of volume-sensitive hormone systems (plasma renin activity, aldosterone, arginine vasopressin, catecholamines) are conspicuously absent in patients with cirrhosis and in animals with experimentally induced liver damage.
Efferent factors in the volume control in cirrhosis (1) Role of the renin-angiotensin-aldosterone axis. The reninangiotensin-aldosterone axis is often stimulated in patients with moderately advanced cirrhosis [31, [50] [51] [52] [53] . The initial causative factors for this stimulation could be arterial hypotension, decreased "effective' blood volume [14] , hepatic venous congestion [47] , portal hypertension [48] , adrenal venous congestion [59] , or diminished distal delivery of sodium chloride to the macula densa.
In some patients with cirrhosis [51] , but not in others [52] , administration of angiotensin II antagonists results in arterial hypotension [51] . This finding suggests that the renin-angiotensin system may be activated in defense of arterial blood pressure in cirrhosis [51] .
Bosch et a! [53] and Arroyo et a! [54] have recently shown in a large group of patients with cirrhosis but without azotemia that activation of the renin-angiotensin-aldosterone axis in cirrhosis is a late and ominous prognostic sign (50% survival 6 months) and is associated with avid sodium retention and increased wedged hepatic venous pressure. Interestingly, inulin clearance in these patients was normal, thus demonstrating that the early avid sodium retention is due to increased tubular sodium reabsorption rather than a fall in GFR.
In cirrhotic patients the increased plasma renin activity can be decreased into the normal range by salt loading or neck out water immersion [31] ; however, a natriuresis following these maneuvers does not always occur [31] .
Epstein et al [31] assessed the role of hyperaldosteronism in the salt retention of cirrhosis by subjecting cirrhotic patients to the aldosterone antagonist before and after water immersion. Spironolactone administration without water immersion resulted in only modest natriuresis. In contrast, when patients on spironolactone were immersed they demonstrated a substantial increase in sodium excretion. The finding that this natriuresis was also associated with an increase in free water clearance and potassium excretion, indicated that water immersion increased solute and water delivery to the distal nephron. Thus, both decreased distal delivery of sodium and aldosterone-mediated enhanced distal reabsorption of sodium may be involved in the renal sodium retention in the cirrhotic patient.
It must be emphasized, however, that administration of spironolactone alone (400 mg/day for at least 2 weeks) can effectively induce a natriuresis and abolish the ascites in a great many patients with cirrhosis [60] [61] [62] . Similarly, diuresis and loss of ascites also have been observed in the dog with bile duct ligation after adrenalectomy and replacement therapy with physiological doses of glucocorticoids and mineralocorticoids [63] . Finally, there is a possibility that during liver disease the renal tubule becomes supersensitive to the sodium retaining influence of aldosterone and thus the patient fails to "escape" from the sodium-retaining effect of the hormone [64] (Table 4 ).
In summary, clinical experience suggests that in early and moderately advanced cirrhosis, hyperaldosteronism associated with impairment of the "escape phenomenon" is of major importance in sodium retention and ascites formation. When the liver disease progresses further, additional antinatriuretic influences become operative. At this latter stage of cirrhosis distal delivery of sodium declines, probably secondary to a fall in GFR and an increase in proximal tubule reabsorption, and spironolactone alone becomes less effective in alleviating the ascites and edema.
(2) Role of increase in sympathetic nervous activity in the salt retention of cirrhosis (Table 5) . If "underfilling" of the circulation supervenes in cirrhosis, the adrenergic nervous system may be activated [30, 56] . Such an increase in sympathetic tone could contribute to the antinatriuresis of cirrhosis by decreasing total renal blood flow, or its intrarenal distribution, or by acting directly at the tubular epithelial level to enhance sodium reabsorption [65] . Recently, patients with advanced cirrhosis have been found to have strikingly elevated concentrations of (2) There is an increased tubular sensitivity to the salt-retaining action of aldosterone in patients with cirrhosis.
Evidence against a role for hyperaldosteronism in sodium retention in patients with cirrhosis
(1) Dissociation between increase in plasma aldosterone and sodium retention.
(2) Dissociation between plasma aldosterone suppression and natriuresis.
Potential renal vasoconstrictor influences in cirrhosis
(1) Activation of intrarenal renin-angiotensin system (2) Increase in circulating catecholamines and arginine vasopressin (3) Increase in sympathetic (4) Endotoxemia (5) Decrease in circulating kallikrein
Potential renal vasodilatory influences in cirrhosis (I) Increased intrarenal synthesis of vasodilating prostaglandins plasma catecholamines [56] . The patients also had profoundly increased plasma concentration of plasma renin activity, aldosterone, and arginine vasopressin. Moreover, the plasma levels of catecholamines correlated closely with the degree of sodium and water retention. It seems likely that such an increase in adrenergic activity may also contribute to the support of arterial pressure in cirrhotic patients. This speculation is supported by the extreme sensitivity of some patients with cirrhosis to the hypotensive action of phentolamine [66] . The finding of increased endogenous plasma catecholamine levels in cirrhotic patients may explain the blunted pressor response to noradrenaline observed in patients with cirrhosis [16] and dogs with chronic bile duct ligation [17] . Cardiovascular responsiveness to reflex autonomic stimulation may be impaired in patients with cirrhosis. This includes impaired vasoconstrictor response to a variety of stimuli such as ice on the forehead, mental arithmetic, lower body negative pressure, and the Valsalva maneuver [15] . This widespread interference in the peripheral and central autonomic nervous system in cirrhosis could be explained partially by increased occupancy of endogenous catecholamine receptors.
The presence of false neurotransmitters," mainly octopamine, in the central and peripheral nervous systems has been invoked to explain the autonomic dysfunction, the hepatic coma including extrapyramidal changes, as well as the peripheral vasodilatation of cirrhosis [67, 68] . According to this concept, the precursors of false neurotransmitters are produced in the bowel by bacterial degradation of protein. These compounds are usually cleared by the healthy liver, mainly with catabolism by monoamine oxidase. However, in cirrhosis these compounds may bypass the liver and enter the nervous system where they are degraded locally by beta-hydroxylation by relatively nonspecific enzymes. In the central nervous system they may replace normal neurotransmitters and thus interfere with normal synaptic transmission [67, 68] .
In far advanced liver disease when the patients are frankly hypotensive, cirrhotic patients may have a characteristic pattern of blunted pressor response to tyramine and supranormal pressor response to exogenous noradrenaline suggesting tissue depletion of catecholamines resembling that seen after administration of reserpine [69] .
Intrarenal alpha adrenergic blockade in the human has failed to relieve the intense vasoconstriction in patients with cirrhosis [66] . Also, renal denervation or alpha adrenergic blockade does not abolish the antinatriuresis associated with various experimental models of liver injury in the dog [41] . Therefore, increased adrenergic tone cannot entirely account for the antinatriuresis of cirrhosis. In summary, patients with cirrhosis and animals with experimental liver damage suffer from a widespread central and peripheral autonomic dysfunction. This autonomic dysfunction may contribute to the peripheral vasodilatation of cirrhosis. Increased adrenergic tone and an increase in plasma catecholamines in advanced cirrhosis may contribute to renal vasoconstriction and augment renal salt retention. False neurotransmitters may contribute to autonomic dysfunction in cirrhosis, but probably do not dominate in the kidney since they would be expected to dilate rather than constrict the renal circulation.
(3) Role of prostaglandins in volume regulation in cirrhosis (Table 5) , Immersion of sodium-retaining patients with cirrhosis may cause a parallel increase in sodium excretion and urinary prostaglandin E excretion [70] . Also, administration of prostaglandin synthetase inhibitors to patients with decompensated, but not compensated, cirrhosis results in a sharp fall in glomerular filtration, renal plasma flow,and sodium excretion [71] . Moreover, the administration of inhibitors of prostaglandin synthetase may cause a syndrome which mimics hepatorenal syndrome. Thus, the intrarenal vasodilatory action of prostaglandin E seems to be important in the defense of the compromised renal circulation in cirrhosis. Interestingly, however, administration of prostaglandin synthetase inhibitors to cirrhotic patients can partially correct the excessive hyperreninemia and hyperaldosteronism as well as the pressor resistance to angiotensin II. It is not clear at present whether this improvement in angiotensin pressor resistance following administration of prostaglandin synthetase inhibitors is due to suppression of endogenous angiotensin II or to inhibition of local arteriolar synthesis of vasodepressor prostaglandins [71] . Also, there is controversy as to whether urinary prostaglandin E excretion is increased [71] or decreased [72, 73] in decompensated cirrhosis.
In summary, increased synthesis of vasodepressor prostaglandins in nonrenal arteriolar walls may contribute to the peripheral vasodilatation and thus "underfilling" in cirrhosis. tone On the other hand, however, increased intrarenal production of prostaglandin E may be an important defense against powerful vasoconstrictor influences in cirrhosis. Thus, administration of prostaglandin synthetase inhibitors may improve the "underfihling" in the cirrhotic patient but at the same time may worsen the renal failure.
(4) Role of kallikrein-kinin system in the sodium balance in cirrhosis. Infusion of kinins into humans and dogs augments renal blood flow and urinary excretion of sodium [74, 751 . Since plasma prekallikrein and bradykinin levels are subnormal in patients with cirrhosis [76] , it has been suggested that suppression of the kallikrein-kinin system may contribute to the renal vasoconstriction in cirrhosis. No information, however, is available concerning changes in intrarenal activity of the kallikrein-kinin system in the kidney in cirrhosis.
(5) Role of natriuretic hormone in salt retention of cirrhosis.
Patients with cirrhosis [77] and dogs with chronic bile duct ligation [63] lose the ability to "escape" from the sodiumretaining influence of administered mineralocorticoids. This finding has raised the possibility that liver disease is associated with diminished production of natriuretic hormone. This led
Kramer [78] and Wilkinson et al [79] to examine the presence of antinatriuretic activity in plasma and urine of patients with cirrhosis. Utilizing various bioassay systems these authors found diminished antinatriuretic activity in volume expanded patients with cirrhosis. It has been suggested recently that the natriuretic hormone has vasoconstrictor properties [80, 81] . Moreover, an increase in the circulating level of natriuretic hormone has been suggested to explain an increase in blood pressure and exaggerated natriuresis following volume expansion in essential hypertension. It is therefore tempting to speculate that reduction in circulating natriuretic hormone associated with liver disease contributes to the peripheral vasodilatation and hypotension of cirrhosis as well as the renal sodium retention.
(6) Role of vasoactive intestinal peptide. A vasoactive factor isolated from the small intestine has biological activity that mimics many of the associated circulatory and metabolic disorders of cirrhosis [82, 83] . Among these are peripheral vasodilatation, increased cardiac output, pulmonary shunting, and hyperventilation. Since this substance is inactivated by the liver [83] , it has been suggested that in cirrhosis enough vasoactive intestinal peptide may escape inactivation by the diseased liver and enter the systemic circulation, thereby contributing to the circulatory disorder. (7) Role of cholemia in the circulatory disturbance of cirrhosis. Acute intravenous [84] or intrarenal [85] infusion of diluted bile in dogs causes natriuresis and kaliuresis. The bile component responsible for this effect is bile salts rather than bilirubin. However, isolated chronic cholemia induced in dogs by choledochocaval anastomosis results in peripheral vasodilatation, hypotension, and sodium retention [86] . Under these chronic conditions the depressor effect of cholemia on the circulation overrides the natriuretic properties of bile present in the circulation. Thus, when jaundice complicates cirrhosis peripheral vasodilatation may aggravate "underfilling" of the circulation.
(8) Role of vasopressin in water retention in cirrhosis. An impaired ability to excrete a water load and hyponatremia are common accompaniments of patients with decompensated cirrhosis. Several maneuvers which increase central blood volume and enhance fluid delivery to the nephron, including infusion of mannitol [87] , saline [87] , saline plus albumin [21] , ascites fluid [88] , saline plus albumin [21] , and water immersion to the neck [29] have been shown to improve urinary dilution and water excretion in patients with cirrhosis. These results have been interpreted by some investigators to suggest that intrarenal mechanisms are responsible for the impaired water excretion of cirrhosis. These maneuvers which cause volume expansion, however, could also suppress nonosmotic (baroreceptor-mediated) release of arginine vasopressin and thereby facilitate water excretion. Some support for the latter possibility are the findings that administration of alcohol to suppress vasopressin release [89] or demeclocycline which antagonizes the peripheral action of vasopressin [90, 91] improves renal water excretion in cirrhotic patients. Moreover, in experimental liver congestion [92] , portal hypertension [48] , common bile duct ligation [49] , and cirrhosis [93] , impaired water excretion has been demonstrated to be primarily due to nonosmotic vasopressin release.
Recent studies by Bichet et al [55, 56] also support an important role for vasopressin in the water retention associated with cirrhosis. On the basis of the ability to excrete a 20-mi/kg water load, the cirrhotic patients could be divided prospectively into two groups, "excretors" who excreted more than 80% of the water load in 5 hr and "nonexcretors" who excreted a mean of only 27% of the water load in 5 hr. The nonexcretor group had lower serum sodium and osmolalities and higher plasma vasopressin levels after the water load. Evidence for a decrease in "effective" blood volume which would be expected to stimulate baroreceptor-mediated vasopressin release included lower plasma albumin concentration, higher heart rates, higher plasma renin activity, plasma aldosterone, and plasma catecholamines in the nonexcretor patients. Moreover, water immersion to the neck enhanced central blood volume, decreased plasma vasopressin and improved the nonexcretor cirrhotic patients' capacity to excrete a water load [94] . Thus, it seems clear that the nonosmotic release of vasopressin, in addition to any intrarenal mechanism, is important in the impaired water excretion of cirrhosis, Decreased hepatic metabolism of vasopressin could also contribute to elevated plasma vasopressin levels in cirrhotic patients. Whether or not vasopressin also exerts a vascular effect in cirrhotic patients remains to be investigated.
Conclusion
In conclusion, we would like to propose an integrated hypothesis for sodium and water retention in the cirrhotic patient (Fig. 1) . We believe that neither the "overflow" nor "underfilling" theories of sodium retention and ascites are alone adequate to explain totally the observed phenomena in the cirrhotic patient. It is proposed that both a decrease in "effective" blood volume with secondary renal sodium retention and primary renal sodium retention (perhaps initiated by increased intrahepatic pressure) are involved in cirrhosis.
Because the absence of intrahepatic pressure elevation secondary to a side-to-side, but not end-to-end, portal caval shunt abolishes renal sodium retention in experimental toxic cirrhosis (Levy, unpublished observation), it can be suggested that elevated intrahepatic pressure provides the afferent stimulus for "primary" renal sodium retention in the "overflow" theory of ascites formation. Portal venous hypertension in the dog, an expected accompaniment of intrahepatic pressure elevation, has been shown to increase both renal sympathetic and plasma renin activity [48] . Moreover, a decrease in "effective" blood volume in cirrhosis secondary to peripheral vasodilatation, and enhanced by hypoalbuminemia and splanchnic venous pooling, would be expected to stimulate the sympathetic nervous system. In this regard, patients with decompensated cirrhosis and ascites have been shown recently to have substantially elevated levels of plasma norepinephrine levels [56] . Renal venous catecholamine levels have also been shown to be higher than peripheral plasma norepinephrine concentrations in cirrhotic patients [951. The presence of higher pulse rates and plasma norepinephrine levels in decompensated versus compensated cirrhotic patients also support a physiologically important activation of the sympathetic nervous system.
Thus, there is substantial evidence for the central role of activation of the sympathetic nervous system as proposed in the present hypothesis for sodium and water retention in cirrhosis. Moreover, the resultant renal nerve stimulation is proposed to stimulate renin release as well as decrease GFR and renal blood flow. The effect of angiotensin II to decrease glomerular capillary permeability, probably by constricting mesangial cells and decreasing glomerular capillary surface area, is well documented [961. Also, the effect of renal nerve stimulation to increase proximal tubular sodium reabsorption has also been demonstrated in micropuncture studies [97] . Angiotensin II receptors have also been found on isolated proximal tubule cells and may also enhance proximal tubular sodium reabsorption [981. This effect, however, needs further documentation. The resultant decrease in distal sodium delivery, secondary to a lowered filtered load of sodium and enhanced proximal sodium reabsorption as caused by renal nerve stimulation and increased angiotensin II, is proposed as the cause for failure of cirrhotic patients to "escape" from the sodium-retaining effect of aldosterone. Thus, neither enhanced proximal sodium reabsorption nor increased aldosterone-mediated distal sodium reabsorption alone, but rather both in combination, are proposed to account for renal sodium retention in cirrhosis. The nonosmotic release of vasopressin and diminished distal fluid delivery are proposed to account for the renal water retention in cirrhosis.
OR! S. BETTER ROBERT W. SCHRIER Haifa, Israel, and Denver, Colorado
